The Severe Asthma Research Program III-Boston Clinical Site
N/A
Asthma is a disease characterized by inflammation in the airways. The body ...
Status
Completed
Location
Boston Children's Hospital
Start Date
2012-12
Trial ID
NCT01761630
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)
PHASE3
The trial is a randomised, double-blind, placebo-controlled, parallel-group...
Status
Completed
Location
205.417.01061 Boehringer Ingelheim Investigational Site
Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study
N/A
This is a national multicenter, prospective, observational study. It is pla...